Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab

A 70-year-old man was diagnosed with hepatocellular carcinoma (HCC) with portal vein invasion and lung metastases, for which atezolizumab plus bevacizumab (ATZ/BEV) was initiated. After two months, computed tomography revealed tumor growth accompanied by ascites, right ventricular invasion, exacerba...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigefuku, Ryuta, Yoshikawa, Kyoko, Tsukimoto, Mone, Owa, Hirono, Tamai, Yasuyuki, Tameda, Masahiko, Ogura, Suguru, Sugimoto, Ryosuke, Tanaka, Hideaki, Eguchi, Akiko, Sugimoto, Kazushi, Hasegawa, Hiroshi, Iwasa, Motoh, Nakagawa, Hayato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017252/
https://www.ncbi.nlm.nih.gov/pubmed/35732454
http://dx.doi.org/10.2169/internalmedicine.9701-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017252/
https://www.ncbi.nlm.nih.gov/pubmed/35732454
http://dx.doi.org/10.2169/internalmedicine.9701-22

Ejemplares similares